AA
RMD icon

Apriem Advisors’s ResMed RMD Stock Holding History

Apriem Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.53M Sell
23,244
-5,662
-20% -$1.17M 0.39% 42
2026
Q1 		$6.49M Sell
28,906
-1,697
-6% -$423K 0.62% 35
2025
Q4 		$7.37M Sell
30,603
-549
-2% -$140K 0.68% 34
2025
Q3 		$8.53M Sell
31,152
-2,891
-8% -$790K 0.81% 30
2025
Q2 		$8.78M Sell
34,043
-2,957
-8% -$705K 0.93% 26
2025
Q1 		$8.28M Sell
37,000
-12,381
-25% -$2.89M 0.97% 28
2024
Q4 		$11.3M Sell
49,381
-16,214
-25% -$3.9M 1.29% 23
2024
Q3 		$16M Sell
65,595
-3,777
-5% -$844K 1.87% 14
2024
Q2 		$13.3M Sell
69,372
-486
-0.7% -$98.6K 1.63% 16
2024
Q1 		$13.8M Buy
69,858
+5,029
+8% +$921K 1.74% 16
2023
Q4 		$11.2M Buy
64,829
+2,118
+3% +$325K 1.49% 21
2023
Q3 		$9.27M Buy
+62,711
New +$11.3M 1.36% 24

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Apriem Advisors's RMD Position: Q2 2026 in Review

Apriem Advisors reduced its ResMed (RMD) stake by 20% in Q2 2026, selling an estimated $1.17M and leaving 23,244 shares worth $4.53M. The position accounts for 0.39% of the portfolio, ranked #42.

Apriem Advisors first reported a position in RMD in Q3 2023 and has held it in 12 quarters since. The position peaked at $16M in Q3 2024. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Apriem Advisors held 23,244 shares of ResMed worth $4.53M as of Q2 2026.
  • Apriem Advisors sold 5,662 ResMed shares in Q2 2026, an estimated $1.17M.
  • ResMed made up 0.39% of Apriem Advisors's portfolio in Q2 2026, its #42 holding.
  • Apriem Advisors first reported a position in ResMed in Q3 2023 and has held it in 12 quarters since.
  • Apriem Advisors's ResMed position peaked at $16M in Q3 2024.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Apriem Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.